|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
WO1999065867A1
(en)
|
1998-06-17 |
1999-12-23 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
SK15522001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s tromi arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
WO2001014882A1
(fr)
|
1999-08-23 |
2001-03-01 |
Bml, Inc. |
Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
US7144913B2
(en)
|
2001-05-23 |
2006-12-05 |
Merck Frosst Canada & Co. |
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
|
|
WO2003006011A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
AU2002336532C1
(en)
*
|
2001-09-14 |
2008-10-16 |
Amgen, Inc |
Linked biaryl compounds
|
|
EP1558614B1
(en)
|
2002-10-30 |
2010-09-01 |
Merck Frosst Canada Ltd. |
Pyridopyrrolizine and pyridoindolizine derivatives
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
EP1585511B1
(en)
|
2002-12-20 |
2013-01-23 |
Amgen Inc. |
Asthma and allergic inflammation modulators
|
|
ATE316077T1
(de)
|
2003-04-25 |
2006-02-15 |
Actimis Pharmaceuticals Inc |
Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
|
|
RU2006109108A
(ru)
|
2003-10-14 |
2007-11-20 |
Оксаген Лимитед (GB) |
Соединения, обладающие активностью антагонистов crth2 рецепторов
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
US8008525B2
(en)
|
2003-11-26 |
2011-08-30 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
US7737295B2
(en)
|
2004-04-13 |
2010-06-15 |
Merck Sharp & Dohme Corp. |
CETP inhibitors
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
BRPI0515209A
(pt)
|
2004-08-17 |
2008-07-08 |
Galderma Reseach & Dev S N C |
compostos, composição cosmética, usos de uma composição e composição farmacêutica
|
|
AU2005286718A1
(en)
|
2004-09-21 |
2006-03-30 |
Wyeth |
Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
|
|
BRPI0515522A
(pt)
|
2004-09-21 |
2008-07-29 |
Athersys Inc |
composto, composição farmacêutica. métodos de inibir a ligação de ligandos endógenos ao receptor crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor crth-2 em um animal e de preparar um composto, e, kit
|
|
WO2006052798A2
(en)
|
2004-11-08 |
2006-05-18 |
Merck & Co., Inc. |
Method of treating pathological blushing
|
|
AP2007003980A0
(en)
|
2004-11-23 |
2007-06-30 |
Pfizer Prod Inc |
Dibenzylamine compounds and derivatives
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
EP2407459A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
WO2007039736A1
(en)
|
2005-10-06 |
2007-04-12 |
Astrazeneca Ab |
Novel compounds
|
|
TW200732296A
(en)
*
|
2005-12-15 |
2007-09-01 |
Astrazeneca Ab |
Novel compounds
|
|
SI1976828T1
(sl)
|
2005-12-29 |
2017-07-31 |
Celtaxsys, Inc. |
Diaminski derivati kot inhibitorji levkotrien A4 hidrolaze
|
|
AU2007257841A1
(en)
*
|
2006-06-09 |
2007-12-21 |
Icos Corporation |
Substituted phenyl acetic acids as DP-2 antagonists
|
|
SG174069A1
(en)
*
|
2006-08-21 |
2011-09-29 |
Array Biopharma Inc |
4-substituted phenoxyphenylacetic acid derivatives
|
|
EP2662353A3
(en)
|
2007-06-12 |
2014-04-02 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN101687844B
(zh)
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
|
WO2009043747A2
(en)
|
2007-10-01 |
2009-04-09 |
F. Hoffmann-La Roche Ag |
N-heterocyclic biaryl carboxamides as ccr receptor antagonists
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
ES2442717T3
(es)
|
2008-01-18 |
2014-02-13 |
Atopix Therapeutics Limited |
Compuestos que tienen actividad antagonista de CRTH2
|
|
EA018901B1
(ru)
|
2008-02-01 |
2013-11-29 |
ПАНМИРА ФАРМАСЬЮТИКАЛС, ЭлЭлСи |
N,n-дизамещенные аминоалкилбифенилы в качестве антагонистов рецепторов простагландина d
|
|
US20110098352A1
(en)
|
2008-02-01 |
2011-04-28 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
EP2268611A2
(en)
*
|
2008-04-02 |
2011-01-05 |
Amira Pharmaceuticals, Inc. |
Aminoalkylphenyl antagonists of prostaglandin d2 receptors
|
|
US8071807B2
(en)
*
|
2008-07-03 |
2011-12-06 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
US8378107B2
(en)
|
2008-10-01 |
2013-02-19 |
Panmira Pharmaceuticals, Llc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
SG178109A1
(en)
|
2009-07-31 |
2012-03-29 |
Panmira Pharmaceuticals Llc |
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
|
|
CN102596193A
(zh)
|
2009-07-31 |
2012-07-18 |
潘米拉制药公司 |
Dp2受体拮抗的皮肤调配物
|